Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zinc gluconate + ibuprofen + chlorphenamine maleate
- Development stage
- Unknown
- Lead developer
- Nanjing Hanxin Pharmaceutical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination medication contains zinc gluconate, ibuprofen, and chlorphenamine maleate, developed by Nanjing Hanxin Pharmaceutical Technology and marketed by its subsidiary Nanjing Cuccess Pharmaceutical Co., Ltd. It is formulated as oral granules for the symptomatic relief of the common cold and upper respiratory tract infections. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), acts by inhibiting cyclooxygenase (COX) enzymes to provide analgesic, antipyretic, and anti-inflammatory effects. Chlorphenamine maleate is a first-generation H1-antihistamine that blocks histamine receptors to alleviate symptoms like rhinorrhea and sneezing. Zinc gluconate is included as a nutritional supplement to support immune function. The product is approved and marketed in China.
- Other names
- Zinc Gluconate, Ibuprofen and Chlorphenamine Maleate GranulesCombination cold/cough granules
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on zinc gluconate + ibuprofen + chlorphenamine maleate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on zinc gluconate + ibuprofen + chlorphenamine maleate.